http://www.catalystpharma.com
Catalyst Pharmaceuticals, Inc. Company Intro
Our company is committed to developing novel, safe, and efficacious therapies to improve the lives of people with rare diseases.
Industry
Healthcare
Catalyst Pharmaceuticals, Inc. Headquaters
355 Alhambra Circle
Coral Gables,33134
United States
Catalyst Pharmaceuticals, Inc. Share price
14 Sep 2022 08:58 GMT
$16.16
1.01 (6.67 %)
Catalyst Pharmaceuticals, Inc. Market cap
$1.578 B
WMC RANKING
2022
Catalyst Pharmaceuticals, Inc. # 55
BiotechnologyLatest Catalyst Pharmaceuticals, Inc. News
27 Sep 2022
Stock of Catalyst Pharmaceuticals Inc. (CPRX) performance ...
Catalyst Pharmaceuticals Inc. [NASDAQ: CPRX] stock has seen the most recent analyst activity on August 24, 2022, when ROTH Capital downgraded its rating to a...
27 Sep 2022
A company insider recently sold 60000 shares of Catalyst ...
Catalyst Pharmaceuticals Inc.'s recent filing unveils that its VP, Treasurer and CFO GRANDE ALICIA unloaded Company's shares for reported $0.71 million on...
27 Sep 2022
NAM Extends Catalyst Phase of the Healthy Longevity Global ...
Ultimately, the NAM selected 25 Catalyst Awardees in 2022. ... Matthew O'Connor, Underdog Pharmaceuticals; CARS Silver: Mental Health Screening and Targeted...
WMC Market Score
WMC Market to Revenue Score
Catalyst Pharmaceuticals, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Catalyst Pharmaceuticals, Inc. | USD | $120,141 | $62,167 | $72,220 | $15,780B | 55 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $754,300B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $713,610B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $150,520B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Catalyst Pharmaceuticals, Inc. Social Followers vs Top 4 Industry Competitors
Catalyst Pharmaceuticals, Inc. Post vs Top 4 Industry Competitors
Catalyst Pharmaceuticals, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Catalyst Pharmaceuticals, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Catalyst Pharmaceuticals, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Catalyst Pharmaceuticals, Inc. | 1.31 | 2.08 | 0.03 | 0 | 0 | 0 | 0.95 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 22 | 0 | 0 | 28.52 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 33 | 0 | 0 | 34.78 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 22 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 47.37 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
